Moody’s affirms ‘A1’ rating on Rush University Medical Center’s bonds

Moody’s Investors Service affirmed the “A1” rating on Chicago-based Rush University Medical Center’s $475 million of fixed-rate revenue bonds.

Advertisement

The rating affirmation is based on a number of factors, including RUMC’s strong operating performance, modest balance sheet metrics, challenging payer environment and competitive market.

The outlook is stable, reflecting Moody’s Investors Service’s expectation RUMC will maintain its solid operating performance.

More articles on healthcare finance:
9 recent hospital outlook and credit rating actions
Moody’s affirms ‘A1’ rating on Phoebe Putney Memorial Hospital’s bonds
Fitch assigns ‘BB+’ rating to Orange Regional Medical Center bonds

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.